Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors

Cancer Research

Volumn 72, Issue 18, 2012, Pages 4777-4786

  You, Jian ^a   Zhang, Rui ^b   Xiong, Chiyi ^b   Zhong, Meng ^b   Melancon, Maritess ^b   Gupta, Sanjay ^b   Nick, Alpa M ^b   Sood, Anil K ^b   Li, Chun ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; EPHRIN RECEPTOR B4; GOLD NANOSPHERE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG RELEASE; DRUG TARGETING; DRUG TUMOR LEVEL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE TRACING; LASER; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MOUSE; NANOFABRICATION; NANOPHARMACEUTICS; NEAR INFRARED LASER; NONHUMAN; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PHOTOTHERMAL ABLATION; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; SCAR FORMATION; TREATMENT OUTCOME; TUMOR; TUMOR CELL CULTURE; TUMOR REGRESSION; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; DOXORUBICIN; DRUG CARRIERS; FEMALE; GOLD; INFRARED RAYS; LASER THERAPY, LOW-LEVEL; MICE; NANOSPHERES; NEOPLASMS, EXPERIMENTAL; RECEPTOR, EPHB4; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84866427416     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1003     Document Type: Article

References (38)

1. Bardhan R, Lal S, Joshi A, Halas NJ. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res 2011;44:936-46.
2. Melancon M, Lu W, Li C. Gold-based magneto/optical nanostructures: challenges for in vivo applications in cancer diagnostics and therapy. Mater Res Bull 2009;34:415-21.
3. Melancon MP, Lu W, Yang Z, Zhang R, Cheng Z, Elliot AM, et al. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther 2008;7:1730-9.
4. Lu W, Xiong C, Zhang G, Huang Q, Zhang R, Zhang JZ, et al. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res 2009;15:876-86.
5. You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano 2010;4:1033-41.
6. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 2005;6:462-75.
7. Dodelet VC, Pasquale EB. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 2000;19:5614-9.
8. Nakamoto M, Bergemann AD. Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis. Microsc Res Tech 2002;59:58-67.
9. Walker-Daniels J, Hess AR, Hendrix MJ, Kinch MS. Differential regulation of EphA2 in normal and malignant cells. Am J Pathol 2003;162:1037-42.
10. Brantley-Sieders DM, Caughron J, Hicks D, Pozzi A, Ruiz JC, Chen J. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. J Cell Sci 2004;117:2037-49.
11. Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci U S A 2004;101:5583-8.
12. Battaglia AA, Sehayek K, Grist J, McMahon SB, Gavazzi I. EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing. Nat Neurosci 2003;6:339-40.
13. Goldshmit Y, Galea MP, Wise G, Bartlett PF, Turnley AM. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 2004;24:10064-73.
14. Xia G, Kumar SR, Stein JP, Singh J, Krasnoperov V, Zhu S, et al. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene 2006;25:769-80.
15. Koolpe M, Burgess R, Dail M, Pasquale EB. EphB receptor-binding peptides identified by phage display enable design of an antagonist with Ephrin-like affinity. J Biol Chem 2005;280:17301-11.
16. Erber R, Eichelsbacher U, Powajbo V, Korn T, Djonov V, Lin JH, et al. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J 2006;25:628-41.
17. Kumar SR, Scehnet JS, Ley EJ, Singh J, Krasnoperov V, Liu R, et al. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res 2009;69:3736-45.
18. Kumar SR, Singh J, Xia GB, Krasnoperov V, Hassanieh L, Ley EJ, et al. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 2006;169:279-93.
19. Xiong C, Huang M, Zhang R, Song S, Lu W, Flores L II, et al. In vivo small-animal PET/CT of EphB4 receptors using 64Cu-labeled peptide. J Nucl Med 2011;52:241-8.
20. Ozgur E, Heidenreich A, Dagtekin O, Engelmann U, Bloch W. Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue. Urol Oncol 2011;29:78-84.
21. Wang X, Qian X, Beitler JJ, Chen ZG, Khuri FR, Lewis MM, et al. Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles. Cancer Res 2011;71:1526-32.
22. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010;464:1067-70.
23. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010;9:615-27.
24. Lu W, Zhang G, Zhang R, Flores LG II, Huang Q, Gelovani JG, et al. Tumor site-specific silencing of NF-kappa B p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res 2010;70:3177-88.
25. Lu D, Wientjes MG, Lu Z, Au JL. Tumor priming enhances delivery and efficacy of nanomedicines. J Pharmacol Exp Ther 2007;322:80-8.
26. Melancon MP, Elliott A, Ji X, Shetty A, Yang Z, Tian M, et al. Theranostics with multifunctional magnetic gold nanoshells: photothermal therapy and t2*magnetic resonance imaging. Invest Radiol 2011;46:132-40.
27. Eikenes L, Tari M, Tufto I, Bruland OS, de Lange Davies C. Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts. Br J Cancer 2005;93:81-8.
28. Eikenes L, Bruland OS, Brekken C, Davies Cde L. Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts. Cancer Res 2004;64:4768-73.
29. Diop-Frimpong B, Chauhan VP, Krane S, Boucher Y, Jain RK. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci U S A 2011;108:2909-14.
30. Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res 2011;44:947-56.
31. You J, Zhang R, Zhang G, Zhong M, Liu Y, Van Pelt CS, et al. Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-trigged drug release. J Control Release 2012;158:319-28.
32. Gu Y, Chen WR, Xia M, Jeong SW, Liu H. Effect of photothermal therapy on breast tumor vascular contents: noninvasive monitoring by near-infrared spectroscopy. Photochem Photobiol 2005;81:1002-9.
33. Gough-Palmer AL, Gedroyc WM. Laser ablation of hepatocellular carcinoma - a review. World J Gastroenterol 2008;14:7170-4.
34. Muralidharan V, Malcontenti-Wilson C, Christophi C. Interstitial laser hyperthermia for colorectal liver metastases: the effect of thermal sensitization and the use of a cylindrical diffuser tip on tumor necrosis. J Clin Laser Med Surg 2002;20:189-96.
35. Vogl TJ, Straub R, Zangos S, Mack MG, Eichler K. MR-guided laser-induced thermotherapy (LITT) of liver tumours: experimental and clinical data. Int J Hyperthermia 2004;20:713-24.
36. Vogl TJ, Straub R, Eichler K, Sollner O, Mack MG. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 2004;230:450-8.
37. Rosenberg C, Puls R, Hegenscheid K, Kuehn J, Bollman T, Westerholt A, et al. Laser ablation of metastatic lesions of the lung: long-term outcome. Am J Roentgenol 2009;192:785-92.
38. Gupta S, Stafford RJ, Javadi S, Ozkan E, Ensor JE, Wright KC, et al. Effects of near-infrared laser irradiation of biodegradable microspheres containing hollow gold nanospheres and paclitaxel administered intraarterially in a rabbit liver tumor model. J Vasc Interv Radiol 2012;23:553-61.